Viewing Study NCT03292133


Ignite Creation Date: 2025-12-25 @ 2:58 AM
Ignite Modification Date: 2026-03-03 @ 2:35 AM
Study NCT ID: NCT03292133
Status: TERMINATED
Last Update Posted: 2025-06-10
First Post: 2017-09-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
Sponsor: Massachusetts General Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-10-31
Start Date Type: ACTUAL
Primary Completion Date: 2021-12-31
Primary Completion Date Type: ACTUAL
Completion Date: 2025-03-04
Completion Date Type: ACTUAL
First Submit Date: 2017-09-21
First Submit QC Date: None
Study First Post Date: 2017-09-25
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-04-10
Results First Submit QC Date: None
Results First Post Date: 2025-06-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-05-22
Last Update Post Date: 2025-06-10
Last Update Post Date Type: ACTUAL